Medical Science Liaison II, Great Plains

Deciphera Pharmaceuticals, Inc.; Denver (CO); On-site; USD 120,000 - 180,000; Full time

Job summary

Deciphera Pharmaceuticals, Inc. is seeking a highly skilled Medical Science Liaison II (MSL II) to serve as a field-based scientific expert within oncology.

You will build credible peer-to-peer relationships with key opinion leaders, clinical investigators, and healthcare professionals, while providing balanced, evidence-based information on our investigational and marketed therapies. You will play a critical role in gathering clinical insights, supporting research, and ensuring our scientific

Qualifications

• Build and maintain credible, peer-to-peer relationships with key opinion leaders (KOLs), clinical investigators, and healthcare professionals.
• Provide balanced, evidence-based information on investigational and marketed therapies.
• Gather clinical insights, support research, and ensure scientific communications are accurate and compliant.

Responsibilities

• Engage with KOLs and external experts to discuss clinical data and disease-state insights.
• Support investigator-initiated and company-sponsored studies and represent the company at scientific meetings and congresses.
• Deliver clear, balanced scientific presentations and communicate field insights to internal stakeholders.

Job description

Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability.

The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together.

Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.

Job Description

We’re looking for a highly skilled Medical Science Liaison II (MSL II) to serve as a field-based scientific expert within oncology. In this role, you will build and maintain credible, peer-to-peer relationships with key opinion leaders (KOLs), clinical investigators, and healthcare professionals, while providing balanced, evidence-based information on our investigational and marketed therapies. You’ll play a critical role in gathering clinical insights, supporting research, and ensuring our scientific communications are accurate, compliant, and strategically aligned.

Key Responsibilities

• Engage with KOLs and external experts to discuss clinical data, emerging research, and disease-state insights
• Support investigator-initiated and company-sponsored studies and represent the company at scientific meetings and congresses
• Deliver clear, balanced scientific presentations and communicate field insights to internal stakeholders